drugset / Trial / NCT01230307

Vitamin D Supplementation for Treatment of Heart Failure

NCT01230307

Phase 4 Terminated 28 enrolled University of Michigan
RandomizedParallel-groupDouble-blindTreatment

Summary

The central objective of this proposal is to establish that vitamin D supplementation in heart failure patients with low vitamin D levels will have improved outcomes compared to placebo. In addition the investigators will also evaluate the role of genetics in regard to vitamin D and heart failure. The investigators will be evaluating what is currently a novel approach of identifying patients with low vitamin D and treating this low vitamin D level. The investigators will be able to evaluate the importance of vitamin D supplementation in these patients and the role of genetics on our defined outcomes.

Timeline

Start
2010-10
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 2000 iu Oral

Indications